Paul G Fisher
Overview
Explore the profile of Paul G Fisher including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
122
Citations
2809
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Monje M, Mahdi J, Majzner R, Yeom K, Schultz L, Richards R, et al.
Nature
. 2024 Nov;
636(8043):E6.
PMID: 39613972
No abstract available.
2.
Monje M, Mahdi J, Majzner R, Yeom K, Schultz L, Richards R, et al.
Nature
. 2024 Nov;
637(8046):708-715.
PMID: 39537919
H3K27M-mutant diffuse midline gliomas (DMGs) express high levels of the disialoganglioside GD2 (ref. ). Chimeric antigen receptor-modified T cells targeting GD2 (GD2-CART) eradicated DMGs in preclinical models. Arm A of...
3.
Lopez M, Bearer C, Christakis D, First L, Fisher P, Ford C, et al.
Acad Pediatr
. 2024 Oct;
24(7S):S227-S230.
PMID: 39428163
No abstract available.
4.
Hansford J, Bouche G, Ramaswamy V, Jabado N, Fonseca A, Moloney S, et al.
J Clin Oncol
. 2024 Aug;
42(35):4126-4129.
PMID: 39110925
Our international team highlights issues with efficacy reports in several studies on DMG with the new drug ONC201.
5.
Monje M, Mahdi J, Majzner R, Yeom K, Schultz L, Richards R, et al.
medRxiv
. 2024 Jul;
PMID: 38978673
H3K27M-mutant diffuse midline gliomas (DMGs) express high levels of the GD2 disialoganglioside and chimeric antigen receptor modified T-cells targeting GD2 (GD2-CART) eradicate DMGs in preclinical models. Arm A of the...
6.
Kohler J, Legro N, Baldridge D, Shin J, Bowman A, Ugur B, et al.
Genet Med
. 2024 May;
26(9):101166.
PMID: 38767059
Purpose: The function of FAM177A1 and its relationship to human disease is largely unknown. Recent studies have demonstrated FAM177A1 to be a critical immune-associated gene. One previous case study has...
7.
Vasireddi S, Draksler T, Bouman A, Kummeling J, Wheeler M, Reuter C, et al.
Europace
. 2024 Jan;
26(1).
PMID: 38195854
Aims: Kleefstra syndrome (KS), often diagnosed in early childhood, is a rare genetic disorder due to haploinsufficiency of EHMT1 and is characterized by neuromuscular and intellectual developmental abnormalities. Although congenital...
8.
Chiang J, Bagchi A, Li X, Dhanda S, Huang J, Pinto S, et al.
Neuro Oncol
. 2023 Jul;
26(1):178-190.
PMID: 37503880
Background: High-grade gliomas (HGG) in young children pose a challenge due to favorable but unpredictable outcomes. While retrospective studies broadened our understanding of tumor biology, prospective data is lacking. Methods:...
9.
Wang E, Gutkin P, Oh J, Pollom E, Soltys S, Grant G, et al.
Neurosurg Focus
. 2022 Nov;
53(5):E2.
PMID: 36321285
Objective: Recurrence of brain tumors in children after the initial course of treatment remains a problem. This study evaluated the efficacy and safety of reirradiation using stereotactic radiosurgery (SRS) in...
10.
Richard M, Yang W, Sok P, Li M, Carmichael S, Von Behren J, et al.
Birth Defects Res
. 2022 Oct;
114(20):1434-1439.
PMID: 36226634
Background: There is emerging evidence that children with complex congenital heart defects (CHDs) are at increased risk for childhood lymphoma, but the mechanisms underlying this association are unclear. Thus, we...